2016/2017 KAN-CBIOO1003U Governance, Control and Contracts in BioBusiness
English Title | |
Governance, Control and Contracts in BioBusiness |
Course information |
|
Language | English |
Course ECTS | 7.5 ECTS |
Type | Mandatory offered as elective |
Level | Full Degree Master |
Duration | One Quarter |
Start time of the course | Autumn, Second Quarter |
Timetable | Course schedule will be posted at calendar.cbs.dk |
Max. participants | 10 |
Study board |
Study Board for MSc. in Business Administration and
Bioentrepreneurship
|
Course coordinator | |
|
|
Several factors
necessitate size restrictions for this course to max. 10 students.
CBS students have to apply through the official CBS course enrollment and credit students must apply by filling out an application form found at www.cbs.dk. |
|
Main academic disciplines | |
|
|
Last updated on 19-04-2016 |
Learning objectives | |||||||||||||||||||||||
To achieve the grade 12, students
should meet the following learning objectives with no or only minor
mistakes or errors: The course enables students to analyze how
their internal operations and external relationships can be
managed, governed and made subject to contracting in an environment
characterized by high uncertainty and where the development of the
firm is dependent on both creative processes and the ability to
handle relationships to stakeholders such as venture capitalists,
suppliers and customers. Students learn to design appropriate
solutions for controlling innovation and product development and to
identify, analyze and account for basic legal problems in
contracts. They become capable at identifying opportunities and
pitfalls of different contractual, control and governance
mechanisms, to understand how they change over the life-cycle of
the firm, and to use the acquired knowledge to build and
successfully develop innovative enterprises.
To achieve 12, as the course’s final grade, the student must perform the following: • Apply relevant theories of contracting, governance and control to managerial problems in both entrepreneurial and established firms in the biotech/pharma sector. • Analyze how firms’ internal operations and external relationships can be managed, governed and made subject to contracting. • Discuss appropriate structures for controlling, contracting and governing innovation and product development. |
|||||||||||||||||||||||
Course prerequisites | |||||||||||||||||||||||
Students must have completed the first year in one of the following cand.merc. programmes: FIR, FSM, ASC, AEF, IMM, IBS, MIB. | |||||||||||||||||||||||
Examination | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Course content and structure | |||||||||||||||||||||||
Bio ventures rely heavily on strategic relationships to external
stakeholders such as large costumer organizations (e.g. global
pharmaceutical firms), partners for out-sourced R&D, suppliers
of venture capital etc. At the same time their internal operations
(largely research) are difficult to manage and control by
conventional approaches. These characteristic tie together a set of
closely related issues in governance, control and contracting. This
course addresses these interdependent issues by teaching key
concepts and tools within each of three issues as well as their
interdependencies are discussed.
|
|||||||||||||||||||||||
Teaching methods | |||||||||||||||||||||||
The course will mix lectures with casework and simulations. Guest faculty from industry will frequently appear in co‐teaching with academic faculty. | |||||||||||||||||||||||
Student workload | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Further Information | |||||||||||||||||||||||
Course teachers: Sof Thrane (lector), Aleksandra Gregorič(lector), Bjørn Lundqvist (lector) and guest teachers from industry. |
|||||||||||||||||||||||
Expected literature | |||||||||||||||||||||||
Recommended literature:
|